Accordingly, Ndr2 downregulation and/or deletion may promote inflammation and blood–brain/retina barrier dysfunction, contributing to neurodegenerative diseases such as diabetic retinopathy, Parkinson’s or Alzheimer’s disease. This evidence concerns the gene STK38L and early-onset autosomal dominant Alzheimer disease.